Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
Type
Guidance (797)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 391 to 400 of 797
Sort by
Date
Title
Apply sorting
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
TA626
24 June 2020
24 June 2020
Ustekinumab for treating moderately to severely active ulcerative colitis
TA633
17 June 2020
17 June 2020
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer
TA632
10 June 2020
10 June 2020
Larotrectinib for treating NTRK fusion-positive solid tumours
TA630
27 May 2020
27 May 2020
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer
TA628
13 May 2020
13 May 2020
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab
TA629
13 May 2020
13 May 2020
Lenalidomide with rituximab for previously treated follicular lymphoma
TA627
7 April 2020
7 April 2020
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal)
TA625
4 March 2020
4 March 2020
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
TA624
19 February 2020
19 February 2020
Patiromer for treating hyperkalaemia
TA623
13 February 2020
13 February 2020
Previous page
1
…
38
39
Current page
40
41
42
…
80
Page
40
of
80
Next page
Results per page
10
25
50
All
Back to top